SinglePass Inc.’s Patented Device Redefines Biopsy Safety
COSTA MESA, CA / ACCESSWIRE / November 3, 2023 / In a remarkable stride towards improving healthcare, SinglePass, Inc. led by CEO Bill Colone, is redefining the way biopsy procedures are performed, enhancing the safety of these critical processes.
With a primary focus on interventional radiologists, individuals who conduct biopsy procedures, patients, and companies specializing in products for interventional radiologists, SinglePass Inc. is revolutionizing the field with its unique and pioneering product.
At the core of their mission is the commitment to preventing internal bleeding during diagnostic procedures, which significantly improves patient care and peace of mind. The company identified a critical gap in risk management for biopsies, and their device addresses this concern with unparalleled efficiency.
Their core offering is a single-use disposable device designed to significantly improve the safety of biopsy procedures. This device stands out in terms of speed and ease of use and currently has no direct competitors. The technology has garnered significant interest in the medical community with two issued patents to date, in addition to two more patents pending.
"Our motivation comes from the satisfaction of knowing that the technology is making a holistic impact for the medical community and in patient treatment" says founder Bill Colone. We are not only helping save healthcare costs but also reducing expenses for insurance providers and saving valuable nursing time. In addition, we're improving the peace of mind of patients and their families, and delivering more value to medical staff in the process.
Patients undergoing biopsies often experience anxiety about potential bleeding complications. The innovative device effectively mitigates this concern, ensuring that patients have significantly less anxiety during the procedure. This approach to healthcare is a true game-changer, providing patients with the peace of mind they deserve.
The company's values serve as the bedrock of its operations. Upholding the principles of respect, consistency, and delivering results, the team ensures that their product remains reliable and effective. Respect is fundamental in how the team, partners, and customers are treated, while consistency and delivering results are central to their commitment to making a meaningful difference in the healthcare space.
Colone, the visionary behind SinglePass, brings over four decades of experience to the medical device manufacturing industry. With a deep clinical background and expertise, he's the right person to tackle this problem.
In a market that demands novel solutions, SinglePass Inc. offers an unparalleled product that fills a critical need in the healthcare sector. The team is poised to become a trusted expert in the field, thanks to its unique device that improves biopsy procedures and its deep understanding of the challenges faced by interventional radiologists.
For more information about this innovative healthcare solution, please visit their website at SinglePass Inc.
About SinglePass Inc.
SinglePass Inc. is a pioneering medical device manufacturing company dedicated to improving the safety of biopsy procedures. Their unique single-use disposable device addresses the critical need for risk management in biopsies, enhances patient care, and reduces healthcare costs. With an unwavering commitment to respect, consistency, and delivering results, SinglePass Inc. is making a meaningful difference in the healthcare industry.
Contact:
Company Name: Single Pass Inc.
Contact Person: Bill Colone
Website Link: http://www.singlepass.co
SOURCE: Single Pass Inc.
View source version on accesswire.com:
https://www.accesswire.com/799280/singlepass-incs-patented-device-redefines-biopsy-safety
